These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20568013)

  • 1. Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population.
    Klimčáková L; Habalová V; Sivoňová M; Nagy V; Šalagovič J; Židzik J
    Mol Biol Rep; 2011 Feb; 38(2):1287-93. PubMed ID: 20568013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J; Liang D; Wang Y; Lu C; Wu X
    Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population.
    Vilčková M; Jurečeková J; Dobrota D; Habalová V; Klimčáková L; Waczulíková I; Slezák P; Kliment J; Sivoňová MK
    Med Oncol; 2014 Jun; 31(6):987. PubMed ID: 24816842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
    Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups.
    Ma QW; Lin GF; Chen JG; Xiang CQ; Guo WC; Golka K; Shen JH
    Biomed Environ Sci; 2004 Sep; 17(3):291-8. PubMed ID: 15602826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
    Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
    Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
    Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
    Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
    Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients.
    Schnakenberg E; Ehlers C; Feyerabend W; Werdin R; Hübotter R; Dreikorn K; Schloot W
    Clin Genet; 1998 May; 53(5):396-402. PubMed ID: 9660060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
    Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
    Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese.
    Inatomi H; Katoh T; Kawamoto T; Matsumoto T
    Int J Urol; 1999 Sep; 6(9):446-54. PubMed ID: 10510890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.
    Hein DW
    Oncogene; 2006 Mar; 25(11):1649-58. PubMed ID: 16550165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
    Wu H; Wang X; Zhang L; Mo N; Lv Z
    Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.